<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cell Dev Biol</journal-id><journal-id journal-id-type="iso-abbrev">Front Cell Dev Biol</journal-id><journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id><journal-title-group><journal-title>Frontiers in Cell and Developmental Biology</journal-title></journal-title-group><issn pub-type="epub">2296-634X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40012992</article-id><article-id pub-id-type="pmc">PMC11860889</article-id><article-id pub-id-type="publisher-id">1517181</article-id><article-id pub-id-type="doi">10.3389/fcell.2024.1517181</article-id><article-categories><subj-group subj-group-type="heading"><subject>Cell and Developmental Biology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Cross-talk of renal cells through WNT signal transduction in the development of fibrotic kidneys</article-title><alt-title alt-title-type="left-running-head">Chen and Xue</alt-title><alt-title alt-title-type="right-running-head">
<ext-link xlink:href="https://doi.org/10.3389/fcell.2024.1517181" ext-link-type="uri">10.3389/fcell.2024.1517181</ext-link>
</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yuhong</given-names></name><uri xlink:href="https://loop.frontiersin.org/people/2878608/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Xue</surname><given-names>Chao</given-names></name><xref rid="c001" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/1579258/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib></contrib-group><aff>
<institution>Department of Nephrology</institution>, <institution>The Second Affiliated Hospital of Guangxi Medical University</institution>, <addr-line>Nanning</addr-line>, <country>China</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/807141/overview" ext-link-type="uri">Xueli Zhang</ext-link>, Shanghai Cancer Institute, China</p></fn><fn fn-type="edited-by"><p>
<bold>Reviewed by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/2819713/overview" ext-link-type="uri">Wenjian Wang</ext-link>, Guangdong Provincial People&#x02019;s Hospital, China</p><p>
<ext-link xlink:href="https://loop.frontiersin.org/people/2886072/overview" ext-link-type="uri">Huiming Wang</ext-link>, Renmin Hospital of Wuhan University, China</p></fn><corresp id="c001">*Correspondence: Chao Xue, <email>xuechao@stu.gxmu.edu.cn</email>
</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>12</volume><elocation-id>1517181</elocation-id><history><date date-type="received"><day>25</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Chen and Xue.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Chen and Xue</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Chronic kidney disease (CKD) is a progressive condition that can lead to chronic renal failure (CRF), affecting 8%&#x02013;16% of adults globally and imposing a significant burden on healthcare systems. Renal fibrosis is a key pathological hallmark of CKD progression and is linked to poor prognosis. Multiple signaling pathways, including WNT/&#x003b2;-catenin.Aberrant activation of WNT/&#x003b2;-catenin is implicated in renal fibrosis. The roles of renal macrophages and fibroblasts are pivotal in fibrosis progression and prognosis.</p></abstract><kwd-group><kwd>cross-talk</kwd><kwd>kidney fibrosis</kwd><kwd>wnt/&#x003b2;-catenin signaling</kwd><kwd>macrophage</kwd><kwd>fibroblast</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The research was supported by the Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation under Grant No. 2024GXNSFAA999092.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Signaling</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Chronic kidney disease (CKD) has been demonstrated to be a progressive disease that can gradually advance to chronic renal failure (CRF) (<xref rid="B3" ref-type="bibr">Bikbov et al., 2020</xref>). Research indicates that 8%&#x02013;16% of the adult population globally is affected by CKD, and its high prevalence and cost of treatment impose a substantial burden on global healthcare systems (<xref rid="B3" ref-type="bibr">Bikbov et al., 2020</xref>; <xref rid="B9" ref-type="bibr">Chen et al., 2019</xref>). Renal fibrosis represents a pivotal pathological feature of CKD progression (<xref rid="B9" ref-type="bibr">Chen et al., 2019</xref>), and fibrosis is associated with disease progression and poor prognosis (<xref rid="B47" ref-type="bibr">Ruiz-Ortega et al., 2020</xref>; <xref rid="B5" ref-type="bibr">Breyer and Susztak, 2016</xref>).</p><p>Kidney fibrosis is a complex and irreversible pathology involving the activation of multiple signaling pathways, including the WNT/&#x003b2;-catenin signaling pathway, the TGF-&#x003b2;-Smad signaling pathway, and the Notch pathway (<xref rid="B34" ref-type="bibr">Liu, 2011</xref>; <xref rid="B14" ref-type="bibr">Ding et al., 2014</xref>; <xref rid="B40" ref-type="bibr">Murea et al., 2010</xref>). Among these, the WNT/&#x003b2;-catenin signaling pathway plays a significant role in the process of renal fibrosis. WNT signaling is a key regulator in renal development, regulating cell proliferation, differentiation, and tissue patterning, thereby directing normal renal development (<xref rid="B32" ref-type="bibr">Little and McMahon, 2012</xref>). WNT/&#x003b2;-catenin signaling is relatively silent in normal adult kidney; however, it is aberrantly activated in various diseases of the renal, and is implicated in diverse renal pathologies, including renal fibrosis and acute kidney injury (AKI) in CKD (<xref rid="B21" ref-type="bibr">He et al., 2009</xref>; <xref rid="B36" ref-type="bibr">Luo et al., 2018</xref>).</p><p>Despite significant advances in understanding the regulation of WNT/&#x003b2;-catenin pathway expression and its mechanism of action in renal injury have been greatly discovered and elaborated in recent years, the kidney remains a functionally highly differentiated organ, comprising a diverse range of immune cells. Furthermore, renal fibrosis is a progressive disease that is accompanied by the infiltration of a variety of immune cells during its development. The role and function of macrophages undergo significant changes, especially. These changes not only affect the progression of renal fibrosis, but also determine the severity and prognosis of the disease. The role of renal macrophages and fibroblasts in renal fibrosis is discussed in the following section.</p><sec id="s1-1"><title>WNT signal composition</title><p>The WNT signaling pathways comprise both canonical and non-canonical signaling pathways. The canonical WNT signaling pathway is also known as the WNT/&#x003b2;-catenin pathway. The non-canonical WNT signaling pathways include the WNT/Ca<sup>2</sup>&#x0207a; pathway and the WNT/PCP pathway also known as the WNT/c-JNK signaling pathway (<xref rid="B7" ref-type="bibr">Chae and Bothwell, 2018</xref>). From lower organisms to higher organisms, the WNT signaling pathway has retained a high degree of conservation across species. Accumulating evidence indicates that the WNT signaling pathway plays important roles in both disease and health. The canonical WNT signaling pathway exerts significant influence over cell proliferation, differentiation and polarisation during embryonic development. It plays a key role in maintaining tissue homeostasis, stem cell differentiation and self-renewal, and is linked to cancer development. The non-canonical WNT signaling pathway is instrumental for regulating cell polarity, shape and migration, and plays a pivotal role in tissue pattern formation and cell migration during embryonic development (<xref rid="B42" ref-type="bibr">Nusse and Clevers, 2017</xref>; <xref rid="B38" ref-type="bibr">Miao et al., 2020</xref>; <xref rid="B10" ref-type="bibr">Clevers and Nusse, 2012</xref>; <xref rid="B33" ref-type="bibr">Liu et al., 2022</xref>; <xref rid="B12" ref-type="bibr">Dapkunas et al., 2019</xref>).</p></sec><sec id="s1-2"><title>The role of &#x003b2;-catenin-dependent signaling in kidney fibrosis</title><p>WNT/&#x003b2;-catenin signaling is relatively quiescent in normal adult kidneys. However, aberrant activation of WNT/&#x003b2;-catenin signaling has been observed in renal injury, particularly within the renal tubules (<xref rid="B36" ref-type="bibr">Luo et al., 2018</xref>; <xref rid="B15" ref-type="bibr">DiRocco et al., 2013</xref>) (<xref rid="T1" ref-type="table">Table 1</xref>). In mice with tubular &#x003b2;-catenin deletion, the renal function remained normal in the steady state. Conversely, the induction of AKI following the specific knockdown of &#x003b2;-catenin revealed that the absence of endogenous &#x003b2;-catenin exacerbates renal tubular injury and acute renal failure, while also promoting promotes renal tubular cell apoptosis. Under this condition, the mice that had undergone IRI/AKI exhibited more pronounced renal damage.</p><table-wrap position="float" id="T1"><label>TABLE 1</label><caption><p>The role of WNT/&#x003b2;-catenin signaling in various kidney diseases and renal injury repair.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="center" rowspan="1" colspan="1">Stage</th><th align="center" rowspan="1" colspan="1">Models/Species</th><th align="center" rowspan="1" colspan="1">WNT/&#x003b2;-catenin pathway contributes to the development of renal fibrosis</th><th align="center" rowspan="1" colspan="1">Role</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td rowspan="4" align="center" colspan="1">AKI to CKD</td><td align="center" rowspan="1" colspan="1">Mouse</td><td align="center" rowspan="1" colspan="1">Without inflammation and epithelial injury, epithelial-derived Wnt1 directly acts on stromal myofibroblast progenitor cells, thereby driving classical Wnt signaling and fibrosis, leading to the transition from AKI to maladaptive repair and CKD.</td><td align="center" rowspan="1" colspan="1">Detrimental</td><td align="center" rowspan="1" colspan="1">Maarouf, O. H., et al. (2016). Paracrine Wnt1 drives interstitial fibrosis without inflammation by tubulointerstitial cross-talk. <italic>Journal of the American Society of Nephrology</italic>, 27 (3), 781&#x02013;790. <ext-link xlink:href="https://doi.org/10.1681/ASN.2014121188" ext-link-type="uri">https://doi.org/10.1681/ASN.2014121188</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Mouse</td><td rowspan="2" align="center" colspan="1">Transient activation of the Wnt/&#x003b2;-catenin signaling pathway promotes kidney repair following AKI.</td><td align="center" rowspan="1" colspan="1">Transient: protective</td><td align="center" rowspan="1" colspan="1">Li, H., et al. (2022). Tubular &#x003b2;-catenin alleviates mitochondrial dysfunction and cell death in acute kidney injury. <italic>Cell Death &#x00026; Disease</italic>, 13 (12), 1,050. <ext-link xlink:href="https://doi.org/10.1038/s41419-022-05395-3" ext-link-type="uri">https://doi.org/10.1038/s41419-022-05395-3</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Mouse</td><td align="center" rowspan="1" colspan="1">Transient: protective</td><td align="center" rowspan="1" colspan="1">Zhou, D., et al. (2012). Tubule-specific ablation of endogenous &#x003b2;-catenin aggravates acute kidney injury in mice. <italic>Kidney International</italic>, 82 (5), 537&#x02013;547. <ext-link xlink:href="https://doi.org/10.1038/ki.2012.173" ext-link-type="uri">https://doi.org/10.1038/ki.2012.173</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Mouse</td><td align="center" rowspan="1" colspan="1">Persistent and uncontrolled activation of the Wnt/&#x003b2;-catenin signaling pathway promotes the progression from AKI to CKD.</td><td align="center" rowspan="1" colspan="1">Sustained: detrimental</td><td align="center" rowspan="1" colspan="1">Xiao, L., et al. (2015). Sustained activation of Wnt/&#x003b2;-catenin signaling drives AKI to CKD progression. <italic>Journal of the American Society of Nephrology</italic>, 26 (7), 1746&#x02013;1758. <ext-link xlink:href="https://doi.org/10.1681/ASN.2015040449" ext-link-type="uri">https://doi.org/10.1681/ASN.2015040449</ext-link>
</td></tr><tr><td rowspan="7" align="center" colspan="1">CKD</td><td align="center" rowspan="1" colspan="1">Mouse (age-related renal fibrosis)</td><td align="center" rowspan="1" colspan="1">Endogenous Wnt/&#x003b2;-catenin activity antagonists, Klotho and Dickkopf-1 (DKK1), eliminate renal fibrosis in mice</td><td align="center" rowspan="1" colspan="1">Detrimental</td><td align="center" rowspan="1" colspan="1">Miao, J., et al. (2019). Wnt/&#x003b2;-catenin/RAS signaling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction. <italic>Aging Cell</italic>, 18 (1), e13004. <ext-link xlink:href="https://doi.org/10.1111/acel.13004" ext-link-type="uri">https://doi.org/10.1111/acel.13004</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Human (HKC-8)</td><td align="center" rowspan="1" colspan="1">The small molecule inhibitor ICG-001 blocks Wnt/&#x003b2;-catenin signaling, thereby hindering AOPP-induced EMT (epithelial-mesenchymal transition)</td><td align="center" rowspan="1" colspan="1">Detrimental</td><td align="center" rowspan="1" colspan="1">Feng, H., et al. (2020). AGE receptor 1 silencing enhances advanced oxidative protein product-induced epithelial-to-mesenchymal transition of human kidney proximal tubular epithelial cells via RAGE activation. <italic>Biochemical and Biophysical Research Communications</italic>, 529 (3), 735&#x02013;741. <ext-link xlink:href="https://doi.org/10.1016/j.bbrc.2020.06.144" ext-link-type="uri">https://doi.org/10.1016/j.bbrc.2020.06.144</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Mouse</td><td align="center" rowspan="1" colspan="1">Blocking Wnt secretion by gene deletion of Wls in renal tubules significantly inhibits myofibroblast activation and reduces renal fibrosis following unilateral ureteral obstruction. Blocking Wnt secretion in renal tubules (rather than in fibroblasts) suppresses fibroblast activation and reduces renal fibrosis following injury</td><td rowspan="2" align="center" colspan="1">Detrimental</td><td rowspan="2" align="center" colspan="1">Zhou, D., et al. (2017). Tubule-derived Wnts are required for fibroblast activation and kidney fibrosis. <italic>Journal of the American Society of Nephrology</italic>, 28 (4), 944&#x02013;957. <ext-link xlink:href="https://doi.org/10.1681/ASN.2016080902" ext-link-type="uri">https://doi.org/10.1681/ASN.2016080902</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Human (IgAN/FSGS<break/>MN)</td><td align="left" rowspan="1" colspan="1">Biopsy specimens from CKD patients show increased expression of multiple Wnt proteins, primarily in the renal tubular epithelium</td></tr><tr><td align="center" rowspan="1" colspan="1">Human (MCN/IgAN/DN/MN/LN)</td><td align="center" rowspan="1" colspan="1">In various human CKD conditions, upregulation of WNT9a has been observed</td><td align="center" rowspan="1" colspan="1">Detrimental</td><td align="center" rowspan="1" colspan="1">Luo, C., et al. (2018). Wnt9a promotes renal fibrosis by accelerating cellular senescence in tubular epithelial cells. <italic>Journal of the American Society of Nephrology</italic>, 29 (4), 1,069&#x02013;1,083. <ext-link xlink:href="https://doi.org/10.1681/ASN.2017050574" ext-link-type="uri">https://doi.org/10.1681/ASN.2017050574</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Human (LN)</td><td align="center" rowspan="1" colspan="1">The classical WNT/&#x003b2;-catenin signaling pathway is activated in patients with lupus nephritis</td><td align="center" rowspan="1" colspan="1">Detrimental</td><td align="left" rowspan="1" colspan="1">Wang, X.-D., et al. (2013). Aberrant activation of the WNT/&#x003b2;-catenin signaling pathway in lupus nephritis. <italic>PLoS ONE</italic>, 8 (3), e84852. <ext-link xlink:href="https://doi.org/10.1371/journal.pone.0084852" ext-link-type="uri">https://doi.org/10.1371/journal.pone.0084852</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Human (DN/FSGS)</td><td align="center" style="color:#212121" rowspan="1" colspan="1">In human proteinuric nephropathy, upregulation of Wnt1 and active &#x003b2;-catenin has been observed in podocytes</td><td align="center" rowspan="1" colspan="1">Detrimental</td><td align="center" rowspan="1" colspan="1">Dai, C., et al. (2009). Wnt/&#x003b2;-catenin signaling promotes podocyte dysfunction and albuminuria. <italic>Journal of the American Society of Nephrology</italic>, 20 (9), 1997&#x02013;2008. <ext-link xlink:href="https://doi.org/10.1681/ASN.2009010019" ext-link-type="uri">https://doi.org/10.1681/ASN.2009010019</ext-link>
</td></tr></tbody></table></table-wrap><p>Some of the subjects died as a result. The stable activation of &#x003b2;-catenin in the tubule of AKI mice has been demonstrated to reduce the apoptosis and necroptosis of renal tubular cell caused by AKI, thereby restoring mitochondrial homeostasis.</p><p>This is achieved by increasing mitochondrial biosynthesis and restoring mitochondrial quality (<xref rid="B29" ref-type="bibr">Li et al., 2022a</xref>). In IRI/AKI kidneys, knockdown of WNT7B resulted in a reduced response of the canonical WNT pathway and a significant reduction in the kidney&#x02019;s ability to repair damage. Conversely, renal repair was enhanced by injection of WNT pathway agonists (<xref rid="B31" ref-type="bibr">Lin et al., 2010</xref>). This suggests that the transient activation of renal &#x003b2;-catenin in the setting of AKI is a protective response that reduces apoptosis and enhances proximal tubular proliferation, facilitating tissue repair and cell regeneration. In light of these findings <xref rid="B56" ref-type="bibr">Tian et al. (2020)</xref>. proposed that sequential combination therapy comprising an initial treatment with a WNT agonist, followed by a WNT antagonist treatment, could prove an effective strategy for reducing the risk of death and fibrosis associated with AKI. On the other side, prolonged &#x003b2;-catenin-dependent signalling activation has been linked to renal fibrosis development.</p><p>This is due to the fact that severe IRI results in prolonged and uncontrolled activation of the Wnt/&#x003b2;-catenin pathway, which in turn leads to the development of kidney fibrosis. This is characterized by the activation of interstitial myofibroblasts and the excessive deposition of extracellular matrix deposition (<xref rid="B68" ref-type="bibr">Zhou et al., 2012</xref>; <xref rid="B62" ref-type="bibr">Xiao et al., 2016</xref>). FoxO1/3 transcription factors compete with TCF/LEF for binding to &#x003b2;-catenin, leading to a shift in signaling from TCF/LEF-dependent pathways to FoxO3-dependent pathways (<xref rid="F1" ref-type="fig">Figure 1</xref>). This inhibits TCF/LEF-dependent transcription and prevents renal tubular epithelial cell (TEC) apoptosis. Accordingly <xref rid="B41" ref-type="bibr">Nlandu-Khodo et al. (2020)</xref> propose that the activation of the &#x003b2;-catenin-dependent signaling pathway in the proximal renal tubule exerts antifibrotic and renal function-protective effects during both periods of unilateral ischemia-reperfusion and aristolochic acid-induced AKI to CKD models, contingent on the presence of FoxO3 transcription factors <italic>in vivo</italic>.</p><fig position="float" id="F1"><label>FIGURE 1</label><caption><p>Activation or silencing of WNT signaling pathway in the presence or absence of WNT ligands 1. Absence of Wnt ligand: In the absence of WNT ligands, the &#x0201c;destruction complex&#x0201d; continues to function and binds to cytoplasmic &#x003b2;-catenin. The rupture complex is mainly composed of Axin, APC, CK1, and GSK3&#x003b2;. The main role of this complex is to phosphorylate cytoplasmic &#x003b2;-catenin, thereby promoting its degradation. In the &#x0201c;destruction complex&#x0201d;, Axin acts as a scaffolding protein, responsible for assembling other proteins. APC regulates the phosphorylation and binding of &#x003b2;-catenin, and GSK3&#x003b2; and CK1 phosphorylate &#x003b2;-catenin. Phosphorylated &#x003b2;-catenin is ubiquitinated and then degraded by the proteasome. The continuous degradation of &#x003b2;-catenin leads to the inability of &#x003b2;-catenin to accumulate in the cytoplasm, preventing it from entering the nucleus to bind to the TCF/LEF transcription factor. In the absence of &#x003b2;-catenin, Groucho binds to TCF/LEF and hinders the transcriptional activation of genes, thus inhibiting the expression of Wnt target genes. FoxO1 and FoxO3 can competitively bind to &#x003b2;-catenin, and this binding prevents the binding of &#x003b2;-catenin to TCF/LEF, thus affecting the downstream of Wnt signaling. Klotho can bind to Wnt (not &#x003b2;-catenin) to block Wnt-triggered &#x003b2;-catenin activation and nuclear translocation. 2. Presence of Wnt signal ligand Binding of Wnt ligands to Frizzled (Fz) and co-receptors LRP5/6 on the cell membrane surface activates Dishevelled (Dsh/DVL) proteins, which inhibit the activity of the &#x0201c;destruction complex&#x0201d;. Axin binds to phosphorylated LRP5/6 and forms a signalling complex that prevents the assembly of the &#x003b2;-catenin destruction complex. GSK3&#x003b2; activity is inhibited, and &#x003b2;-catenin is no longer phosphorylated and degraded, thus accumulating in the cytoplasm. The stabilised &#x003b2;-catenin gradually accumulates and is transferred to the nucleus, where &#x003b2;-catenin binds to TCF/LEF transcription factors to form a transcriptional activation complex, which initiates the expression of Wnt target genes, such as Snail, MMP-7, Twistl, FN1, WISPI, c-Myc, Cyclin D1, Axin2 and LEF1.3 Aberrant activation of the Wnt signaling pathway Aberrant activation of Snail1 inhibits the expression of E-cadherin, and MMP-7, with its proteolytic activity, is able to degrade E-cadherin. E-cadherin and &#x003b2;-catenin form a complex on the cell membrane to maintain the membrane localization of &#x003b2;-catenin. When E-cadherin is degraded, &#x003b2;-catenin, which was originally bound to E-cadherin, is released and accumulates in the cytoplasm. &#x003b2;-Catenin translocates into the nucleus and binds to TCF/LEF transcription factor to initiate the expression of Wnt target gene.</p></caption><graphic xlink:href="fcell-12-1517181-g001" position="float"/></fig><p>The WNT signaling pathway promotes renal fibrosis by activating the &#x003b2;-catenin signaling pathway, which subsequently drives the process of epithelial-mesenchymal transition (EMT). Partial epithelial-mesenchymal transition (p-EMT) refers to a transitional phenotype in which renal tubular epithelial cells (TECs), under specific stimuli, partially lose their epithelial characteristics without fully acquiring mesenchymal cell traits (<xref rid="B52" ref-type="bibr">Sheng and Zhuang, 2020</xref>). Unlike complete EMT, p-EMT cells retain some epithelial features, such as the expression of E-cadherin, while simultaneously expressing certain mesenchymal markers, such as &#x003b1;-SMA or fibronectin. This hybrid phenotype is widely observed in kidney fibrosis and represents a dynamic response of TECs to signals from a damaging microenvironment. Furthermore, fibrotic responses activated through EMT may not require epithelial cells to fully transition into myofibroblasts. Instead, p-EMT cells acquire the ability to produce pro-fibrotic cytokines and growth factors. The p-EMT process is sufficient to induce TEC dysfunction by triggering cell cycle arrest and inflammation, which, in turn, promotes the secretion of pro-fibrotic factors (<xref rid="B35" ref-type="bibr">Lovisa et al., 2015</xref>). This cascade facilitates fibroblast activation and exacerbates kidney fibrosis. p-EMT is an indispensable stage in the development of fibrosis. By intervening in the EMT signaling pathways, particularly the Wnt/&#x003b2;-catenin pathway, potential strategies for treating kidney fibrosis can be developed (<xref rid="B25" ref-type="bibr">Hu et al., 2022</xref>).</p><p>During renal fibrosis, the activation of the WNT signaling pathway has been observed to promote the expression of Snail1 (a member of the zinc finger family of transcription factors), which remains silent throughout the course of kidney development (<xref rid="F1" ref-type="fig">Figure 1</xref>). Aberrant activation of Snail1 directly inhibits the expression of E-cadherin, which blocks and disrupts adhesion between epithelial cells and triggers EMT, thereby initiating a vicious cycle of fibroblast activation and ECM deposition, which exacerbates the fibrosis process. During renal fibrosis, Snai1 not only acts as a target of WNT/&#x003b2;-catenin to regulate the EMT process, but also cooperates with WNT ligands to induce signaling. Snail1 can induce renal tubular epithelial cells (TECs) to acquire a partial epithelial-mesenchymal transition (p-EMT) phenotype. The secretion of fibrosis-related cytokines and growth factors can further activate surrounding stromal cells and immune cells, creating a feedback loop that promotes fibrosis. Modulating p-EMT, rather than complete EMT, may be an effective strategy for treating kidney fibrosis (<xref rid="B19" ref-type="bibr">Grande et al., 2015</xref>).</p><p>Decreased expression of E-cadherin leads to release of &#x003b2;-catenin from adherens junctions and its subsequent translocation to the nucleus (<xref rid="B50" ref-type="bibr">Schunk et al., 2021</xref>; <xref rid="B4" ref-type="bibr">Boutet et al., 2006</xref>; <xref rid="B60" ref-type="bibr">Wang et al., 2010</xref>). Conversely, conditional knockout of Snai1 inhibiting the EMT process maintains the integrity of renal tubular epithelial cells and reduces immune cell infiltration in renal fibrosis, while restoring proliferation, dedifferentiation-related repair and regeneration of the renal parenchyma and thereby reducing interstitial fibrosis (<xref rid="B35" ref-type="bibr">Lovisa et al., 2015</xref>; <xref rid="B44" ref-type="bibr">Qi et al., 2021</xref>) (<xref rid="F1" ref-type="fig">Figure 1</xref>). Expression of RSPO1 is increased in the kidney of obese mice induced by high-fat diet. Knockdown of RSPO1 attenuated renal injury and fibrosis. By binding to LGR4, RSPO1 enhanced &#x003b2;-catenin activity and redistribution in renal tubular cells. This activation of the Wnt/&#x003b2;-catenin signaling pathway promotes the EMT process (<xref rid="B54" ref-type="bibr">Su et al., 2021</xref>).</p></sec><sec id="s1-3"><title>WNT and macrophage</title><p>In the event of kidney injury occurs, macrophages undergo a phenotypic shift and release multiple WNT ligands, which act on epithelial and mesenchymal cells to induce repair and tissue regeneration (<xref rid="B31" ref-type="bibr">Lin et al., 2010</xref>). The secretion of the WNT ligands by renal tubules in a fibrotic environment can significantly has been demonstrated to exert a significant influence on the activity and function of macrophages. Furthermore, activated macrophages have been observed to secrete a diverse range of cytokines, which in turn stimulate the proliferation and activation of fibroblasts. This process ultimately leads to the production of a substantial quantity collagen and other extracellular matrix components by the fibroblasts, resulting in the hyperplasia and exacerbation of renal interstitial fibrosis. The over-activation of fibroblasts further promotes the recruitment and activation of macrophages, thereby forming a vicious circle (<xref rid="F2" ref-type="fig">Figure 2</xref>).</p><fig position="float" id="F2"><label>FIGURE 2</label><caption><p>Role of WNT/&#x003b2;-catenin in regulating interactions of renal tubular epithelia/fibroblasts/macrophages. In the early stages of fibrosis, injured renal tubular epithelial cells release pro-inflammatory mediators and chemokines, among others, to recruit and activate macrophages. Macrophages undergo M1 polarization, and M1 macrophages clear pathogens while secreting large amounts of pro-inflammatory factors, exacerbating tubular and interstitial damage. In the later stages of fibrosis, M2 macrophages (alternatively activated macrophages) gradually replace M1 macrophages. M2 macrophages promote the proliferation and activation of fibroblasts into myofibroblasts by secreting pro-fibrotic factors such as TGF-&#x003b2; and PDGF. Myofibroblasts synthesize large amounts of ECM, including collagen, fibronectin and hyaluronic acid. Fibroblasts promote macrophage activation, and activated macrophages can become myofibroblasts (MMT). The population of inflammatory fibroblasts is part of the intermediate state. In the process of differentiation from fibroblasts to myofibroblasts. Inflammatory fibroblast populations attract macrophages in the early stages of fibrosis and induce monocytes to differentiate into FOLR2+ macrophages. Subsequently, these FOLR2+ macrophages induce the transformation of pro-inflammatory fibroblast populations into myofibroblasts via the WNT/&#x003b2;-catenin pathway. Excessive ECM deposition disrupts the normal structure of renal tissue, leading to progressive irreversibility of fibrosis. Myofibroblasts can also originate from activated macrophages (MMT). Injured renal tubular epithelial cells undergo EMT, and Snail, Twist, ZEB, FOXC, and Ets are important transcription factors in the process of EMT. During EMT, renal tubular epithelial cells lose their polarity and tight junctions, and are gradually transformed into mesenchymal cells with fibroblast-like features, expressing mesenchymal markers such as &#x003b1;-SMA, and producing ECM components (especially Fibronectin) bind to Integrins in the tubular epithelium, altering cell adhesion properties and further inducing EMT. Meanwhile, the mechanical stress of ECM, which increases during fibrosis, can activate mechanosensory signaling pathways in the epithelium, which can also transmit signals via Integrins for the development of EMT. In normal tissue repair, MMPs maintain the dynamic balance of the ECM to promote tissue repair and regeneration by removing damaged tissue and degrading ECM components. But MMPs are over-activated in fibrotic environments, and MMPs not only degrade the basement membrane, making it easier for cells to migrate and facilitating the EMT process, but also participate in the degradation and remodelling of the ECM, which provides space for fibrotic tissue to expand, and release some pro-fibrotic cytokines that are bound and stored by the ECM, such as TGF-&#x003b2;, which further facilitates the activation of fibroblasts and ECM deposition, leading to increased fibrosis. Epithelial cells can autocrine WNT ligand in a fibrotic environment, activating WNT/&#x003b2;-catenin signaling to generate EMT, which allows epithelial cells to progressively lose epithelial properties (cell polarity and tight junctions) and to acquire fibroblastic properties. Paracrine WNT ligand activates neighbouring fibroblasts to promote their proliferation and activation into myofibroblasts, resulting in excessive ECM deposition. Paracrine WNT ligands also modulate the behaviour of macrophages, which undergo M2 polarisation and release pro-fibrotic factors. In fibroblasts, the maintenance of their activated state and pro-fibrotic phenotype is helped by autocrine and paracrine WNT. Activation of the WNT pathway induces pro-inflammatory activation of macrophages and polarization to the M2 phenotype, whereas macrophage-derived WNT affects fibroblast activation and proliferation. Similarly, renal tubular cells can directly interact with WNT ligands derived from macrophages and fibroblasts.</p></caption><graphic xlink:href="fcell-12-1517181-g002" position="float"/></fig></sec><sec id="s1-4"><title>WNT ligands mediate macrophage activation and polarization</title><p>WNT signaling plays a pivotal role in the regulation of organ fibrosis in inflammatory monocytes and tissue-resident macrophages. Activation of WNT3a/&#x003b2;-catenin signaling pathway has been observed to induce phosphorylation and nuclear translocation of STAT3, which in turn has been demonstrated to aggravate macrophages M2 polarization and promote the process of renal fibrosis. On the other hand, the deletion of &#x003b2;-catenin in macrophages reduces macrophage M2 polarization and diminishes renal fibrosis (<xref rid="B16" ref-type="bibr">Feng et al., 2018</xref>).</p><p>WNT ligands have been induced in several types of kidney cells, including tubular epithelial cells, mesenchymal fibroblasts, and fibroblasts (<xref rid="B50" ref-type="bibr">Schunk et al., 2021</xref>). Fibroblasts promote the activation of macrophages, and activated macrophages can be transformed into myofibroblasts. This transformation process is also known as MMT (<xref rid="B8" ref-type="bibr">Chen et al., 2022</xref>) (<xref rid="F2" ref-type="fig">Figure 2</xref>). Macrophage ablation improves myofibroblast activation and prevents myofibroblast accumulation and tissue fibrosis (<xref rid="B43" ref-type="bibr">Pai et al., 2020</xref>). Inflammatory fibroblast populations were found to belong to an intermediate state in the differentiation process from fibroblasts to myofibroblasts using single-cell sequencing technology. In the early stage of fibrosis, the inflammatory fibroblast population attracts macrophages and induces monocytes to differentiate into FOLR2+ macrophages. Subsequently, these FOLR2+ macrophages induce the transformation of pro-inflammatory fibroblast populations into secreting myofibroblasts via activation of the WNT/&#x003b2;-catenin pathway. Inhibition of the &#x003b2;-catenin/TCF interaction or blockade of WNT ligand secretion can block the macrophage-induced transformation of pro-inflammatory fibroblast populations into ECM-secreting myofibroblasts (<xref rid="B11" ref-type="bibr">Cohen et al., 2024</xref>) (<xref rid="F2" ref-type="fig">Figure 2</xref>). In cancer and diabetic nephropathy, inflammatory fibroblast populations attract CD14<sup>+</sup> monocytes and induce their polarization into FOLR2+ macrophages (<xref rid="B18" ref-type="bibr">Fu et al., 2022</xref>; <xref rid="B58" ref-type="bibr">Timperi et al., 2022</xref>). Yi-Lin Zhang et al. found that extracellular matrix remodeling-associated macrophages (EAM) differentiated from infiltrating monocytes were associated with renal fibrosis, and that macrophages and damaged tubules in the later stages of fibrosis were spatially closer to fibroblasts, whereas renal-resident macrophages mainly behaved in a way that promoted tissue repair (<xref rid="B65" ref-type="bibr">Zhang et al., 2024</xref>).</p></sec><sec id="s1-5"><title>Macrophage-derived WNT signal and the effect of macrophage on WNT signaling pathway</title><p>In the kidney, macrophages are an important source of WNT ligands. Macrophage-derived WNTs induced M2 polarization in resting macrophages while expressing fibrosis-associated proteins such as fibronectin, collagen, and &#x003b1;-SMA (<xref rid="B57" ref-type="bibr">Tian et al., 2024</xref>). Macrophage-derived WNT7b can stimulate epithelial responses in damaged kidney tissue and participate in renal or intestinal epithelial repair (<xref rid="B48" ref-type="bibr">Saha et al., 2016</xref>), M2-macrophage-derived WNT7a also promotes the differentiation of lung-resident mesenchymal stem cells into myofibroblasts (<xref rid="B24" ref-type="bibr">Hou et al., 2018</xref>).Blockade of WNT secretion from mouse macrophages resulted in reduced &#x003b2;-catenin activation, decreased macrophage infiltration and activation, suppressed expression of inflammatory cytokines, inhibited activation and proliferation of mesenchymal fibroblasts, attenuated renal inflammation after obstructive injury, and ameliorated renal fibrotic lesions. The Wnt signaling derived from myeloid cells is a major signaling source during the progression of kidney fibrosis. In the study by <xref rid="B57" ref-type="bibr">Tian et al. (2024)</xref>, it was found that Wnts derived from macrophages not only activate macrophages themselves but also affect the activation and proliferation of fibroblasts. In mice with myeloid-specific Wls deletion, a significant reduction in &#x003b2;-catenin activation levels in renal tubular epithelial cells was observed, inhibiting &#x003b2;-catenin signaling and kidney fibrosis after ischemic injury.Macrophage-derived Wnts are key factors in activating &#x003b2;-catenin in renal tubules, and these Wnts may trigger &#x003b2;-catenin activation in tubular cells through a paracrine mechanism.</p><p>In addition to the secretion of WNT ligands and inflammatory cytokines, activated macrophages also secrete matrix metalloproteinases (MMPs). Macrophage-derived MMP-2, MMP-9, and MMP-12 have been shown to be associated with the progression of renal fibrosis (<xref rid="B55" ref-type="bibr">Tan et al., 2013</xref>; <xref rid="B28" ref-type="bibr">La Russa et al., 2024</xref>; <xref rid="B2" ref-type="bibr">Baudier et al., 2024</xref>). MMPs can directly activate the growth factor TGF-&#x003b2;, which affects signaling and promotes fibroblast activation and proliferation, leading to excessive synthesis of collagen and other ECM components (<xref rid="B61" ref-type="bibr">Wozniak et al., 2021</xref>) (<xref rid="F1" ref-type="fig">Figures 1</xref>, <xref rid="F2" ref-type="fig">2</xref>). Of these MMPs, MMP-7 has been identified as a biomarker for kidney fibrosis (<xref rid="B23" ref-type="bibr">Hirohama et al., 2023</xref>). The human MMP-7 gene promoter contains a T-cell factor binding element (TBE) site responsive to the WNT/&#x003b2;-catenin pathway and an activator protein interaction network 1 (AP-1) site required for growth factor activation (<xref rid="B22" ref-type="bibr">He et al., 2012</xref>). MMP-7 has the capacity to activate &#x003b2;-catenin through the process of E-cadherin degradation, which is dependent on its proteolytic activity. This causes enhanced nuclear accumulation of &#x003b2;-catenin, which subsequently activates the independent WNT signalling pathway. Furthermore, the activation of &#x003b2;-catenin can facilitate the binding of TCF to the TBE structural domain in the MMP-7 promoter, thereby inducing the trans-activation of the MMP-7 gene and establishing a positive feedback loop (<xref rid="B22" ref-type="bibr">He et al., 2012</xref>) (<xref rid="F1" ref-type="fig">Figure 1</xref>). Knockdown of MMP-7 significantly inhibited the expression of fibrosis-related genes: fibronectin and &#x003b1;-SMA, Snail1, and PAI-1, and blocked fibronectin deposition in the kidney (<xref rid="B69" ref-type="bibr">Zhou et al., 2017a</xref>).</p></sec><sec id="s1-6"><title>WNT and fibroblast</title><p>Fibroblasts play a central role in fibrosis after kidney injury. After renal injury, macrophages release soluble mediators, in the presence of which fibroblasts are activated and migrate to the site of injury where they proliferate and synthesize and secrete large quantities of collagen as well as other ECM components such as fibronectin and glycosaminoglycans to repair the damaged tissue. However, excessive activation of fibroblasts and continuous ECM deposition can lead to pathological fibrosis (<xref rid="B26" ref-type="bibr">Huang et al., 2023</xref>; <xref rid="B30" ref-type="bibr">Li et al., 2022b</xref>). Secretion of WNT ligand by injured renal tubules affects fibroblast behavior. WNT1 ligand serves as a key activator of the canonical WNT signaling pathway (<xref rid="B10" ref-type="bibr">Clevers and Nusse, 2012</xref>).Overexpression of WNT1 activates &#x003b2;-catenin signaling by binding to Frizzled receptors on the surface of fibroblasts, inducing activation of renal mesangial fibroblasts, promoting the expression of fibronectin, and accelerating the transition from AKI to CKD. Meanwhile, &#x003b2;-catenin-dependent signaling is crucial for sustaining of &#x003b1;SMA + activity in myofibroblasts after AKI. After removal of WNT ligands, activated fibroblasts readily reverted to a resting phenotype, suggesting that ongoing WNT signaling is necessary for fibroblast activation (<xref rid="B62" ref-type="bibr">Xiao et al., 2016</xref>). Activation of fibroblasts and fibrosis were prevented in the absence of WNT ligand in renal tubular epithelial cells, but specific knockdown of WNT ligand in fibroblasts had no significant effect on fibrosis (<xref rid="B67" ref-type="bibr">Zhou et al., 2017b</xref>). However, specific ablation of &#x003b2;-catenin in fibroblasts protected the kidney from apoptosis and inflammatory induced by acute ischemia (<xref rid="B66" ref-type="bibr">Zhou et al., 2018a</xref>). Maarouf et al. found that proximal tubule-derived WNT1 ligand was enough to trigger renal interstitial fibrosis in the absence of any inflammation and epithelial damage by directly targeting interstitial myofibroblast progenitors through paracrine signaling (<xref rid="B37" ref-type="bibr">Maarouf et al., 2016</xref>). Wnt4 activates the Wnt/&#x003b2;-catenin pathway through autocrine signaling and induces mesenchymal fibroblasts to spontaneously differentiate into myofibroblasts (<xref rid="B15" ref-type="bibr">DiRocco et al., 2013</xref>).</p><p>At the same time, the behavior of fibroblasts is also affected by the Sox9 transcription factor. It was found that SOX9 can act as an &#x0201c;on-off switch&#x0201d; to determine cell behavior during the repair process after kidney injury. SOX9 can promote tissue regeneration and the process of fibrosis, where the duration of regenerative response is a key factor in determining fibrotic healing (<xref rid="B1" ref-type="bibr">Aggarwal et al., 2024</xref>; <xref rid="B6" ref-type="bibr">Bugg and Davis, 2024</xref>).The upregulation of SOX9 can regulate the expression of cell cycle-related genes to promote the proliferation of fibroblasts, and also interact with MMPs to enhance the migration ability of fibroblasts, thereby promoting the reconstruction of damaged tissues. However, sustained and severe injury caused by prolonged activation of SOX9 leads to the transformation of fibroblasts into myofibroblasts, which in turn promotes collagen synthesis and ECM deposition.</p><p>SOX9 is present in myofibroblasts in human and mouse CKD. The cellular state activated by the Sox9 transcription factor is a central hub for the formation and maintenance of myofibroblasts and a major source of sustained, biologically active WNT signaling that drives fibrosis after AKI. <xref rid="B1" ref-type="bibr">Aggarwal et al. (2024)</xref> found that after AKI, damaged proximal tubular epithelial cells activate the SOX9 transcription factor, which generates WNT activity to stimulate a fibroproliferative response in neighboring fibroblasts, driving the advancement of AKI to CKD. SOX9 facilitates the activation of fibroblasts and the overdeposition of ECMs by orchestrating the cellular neighborhood of, which promotes the fibrotic process (<xref rid="B6" ref-type="bibr">Bugg and Davis, 2024</xref>). In mouse models of pulmonary and hepatic fibrosis, endothelial cells can activate neighboring fibroblasts, which then migrate and deposit stroma in response to SOX9, but endothelial cell-specific Sox9 deficiency reverses these changes (<xref rid="B59" ref-type="bibr">Trogisch et al., 2024</xref>). Sox9 deficiency attenuates the injury-induced increase in expression of the fibrosis-associated cytoskeletal-associated factor Nav3 (<xref rid="B46" ref-type="bibr">Raza et al., 2021</xref>). SOX9 knockdown significantly inhibited ECM production and granulation tissue proliferation, promoted epithelial regeneration and granulation tissue apoptosis, and attenuated post-injury fibrosis (<xref rid="B39" ref-type="bibr">Morgado-Pascual et al., 2022</xref>; <xref rid="B20" ref-type="bibr">Gu et al., 2022</xref>).</p></sec><sec id="s1-7"><title>Strategies targeting WNT/&#x003b2;-catenin signaling to address renal fibrosis</title><p>Recent research have demonstrated that the WNT/&#x003b2;-catenin signaling pathway is crucial in the initiation and progression of renal fibrosis. Abnormal activation of this signaling pathway is closely associated with excessive proliferation of fibroblasts and ECM. Consequently, therapeutic strategies targeting WNT/&#x003b2;-catenin signaling have increasingly become a focus of research (<xref rid="T2" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="T2"><label>TABLE 2</label><caption><p>Several drugs or natural compound that target WNT/&#x003b2;-catenin signaling pathway.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Drugs/Natural compounds</th><th align="center" rowspan="1" colspan="1">Cell/Mouse model</th><th align="center" rowspan="1" colspan="1">Targeting the WNT/&#x003b2;-catenin pathway mitigate renal fibrosis</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td rowspan="2" align="center" colspan="1">Resveratrol</td><td align="center" rowspan="1" colspan="1">UUO<break/>TEC</td><td align="center" rowspan="1" colspan="1">Resveratrol inhibits fibroblast-myofibroblast differentiation (FMD) and epithelial-mesenchymal transition (EMT), reducing kidney fibrosis. Its antifibrotic effect is associated with the suppression of Wnt/&#x003b2;-catenin and other proliferative signaling pathways, and it partially reverses FMD and EMT by inactivating Smad2/3 signaling, thereby inhibiting the myofibroblast phenotype</td><td align="center" rowspan="1" colspan="1">Zhang, X., et al. (2019). Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation-related signalling pathways. <italic>British Journal of Pharmacology</italic>, 176 (20), 3845&#x02013;3858. <ext-link xlink:href="https://doi.org/10.1111/bph.14842" ext-link-type="uri">https://doi.org/10.1111/bph.14842</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">RAT (IRI)</td><td align="center" rowspan="1" colspan="1">Short-term resveratrol intervention improves kidney repair after ischemia and accelerates tubular recovery. It also targets inflammation and pro-fibrotic signals during maladaptive responses, normalizing these processes. Importantly, resveratrol continues to prevent the transition from acute kidney injury to chronic kidney disease even after 5&#x000a0;months of intervention</td><td align="center" rowspan="1" colspan="1">Mart&#x000ed;nez-Rojas, M. &#x000c1;., et al. (2024). A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats. <italic>The Journal of Physiology</italic>, 602 (12), 2637&#x02013;2653. <ext-link xlink:href="https://doi.org/10.1113/JP285979" ext-link-type="uri">https://doi.org/10.1113/JP285979</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">API</td><td align="center" rowspan="1" colspan="1">Mouse (HN)</td><td align="center" rowspan="1" colspan="1">API improves kidney fibrosis by inhibiting the Wnt/&#x003b2;-catenin pathway. API effectively promotes urinary uric acid (UA) excretion in HN mice and inhibits URAT1 and GLUT.</td><td align="center" rowspan="1" colspan="1">Li, Y., et al. (2021). Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/&#x003b2;-catenin pathway. <italic>Phytomedicine</italic>, 85, 153,585. <ext-link xlink:href="https://doi.org/10.1016/j.phymed.2021.153585" ext-link-type="uri">https://doi.org/10.1016/j.phymed.2021.153585</ext-link>
</td></tr><tr><td rowspan="2" align="center" colspan="1">CoQ10</td><td align="center" rowspan="1" colspan="1">Mouse<break/>UUO</td><td align="center" rowspan="1" colspan="1">CoQ10 inhibits RIP1-RIP3-MLKL-mediated necroinflammatory signaling by suppressing the Wnt3&#x003b1;/&#x003b2;-catenin/GSK-3&#x003b2; pathway in UUO, thereby alleviating renal fibrosis</td><td align="center" rowspan="1" colspan="1">Jiang, Y. J., et al. (2022). Coenzyme Q10 attenuates renal fibrosis by inhibiting RIP1-RIP3-MLKL-mediated necroinflammation via Wnt3&#x003b1;/&#x003b2;-catenin/GSK-3&#x003b2; signaling in unilateral ureteral obstruction. <italic>International Immunopharmacology</italic>, 107, 108,868. <ext-link xlink:href="https://doi.org/10.1016/j.intimp.2022.108868" ext-link-type="uri">https://doi.org/10.1016/j.intimp.2022.108868</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Human</td><td align="center" rowspan="1" colspan="1">The decrease of CoQ 10 concentration can promote the progression of renal insufficiency in patients with CKD.</td><td align="center" rowspan="1" colspan="1">Gvozdj&#x000e1;kov&#x000e1;, A., et al. (2020). Platelet mitochondrial respiration, endogenous coenzyme Q10, and oxidative stress in patients with chronic kidney disease. <italic>Diagnostics</italic>, 10 (3), 176. <ext-link xlink:href="https://doi.org/10.3390/diagnostics10030176" ext-link-type="uri">https://doi.org/10.3390/diagnostics10030176</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Curcumin</td><td align="center" rowspan="1" colspan="1">Rat (DN)</td><td align="center" rowspan="1" colspan="1">Curcumin can reduce the accumulation of extracellular matrix in diabetic nephropathy by restoring the downregulation of Wnt/&#x003b2;-catenin signaling</td><td align="center" rowspan="1" colspan="1">Ho, C., et al. (2016). Curcumin rescues diabetic renal fibrosis by targeting superoxide-mediated Wnt signaling pathways. <italic>American Journal of the Medical Sciences</italic>, 351 (4), 358&#x02013;365. <ext-link xlink:href="https://doi.org/10.1016/j.amjms.2015.12.017" ext-link-type="uri">https://doi.org/10.1016/j.amjms.2015.12.017</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Poricoic acid A</td><td align="center" rowspan="1" colspan="1">Mouse (UUO/adenine-induced CKD)</td><td align="center" rowspan="1" colspan="1">PAA, as a regulator of tryptophan hydroxylase-1 (TPH-1) expression, alleviates renal fibrosis by modulating the Wnt/&#x003b2;-catenin signaling pathway through its effects on &#x003b2;-catenin protein stability and &#x003b2;-catenin-mediated transcription</td><td align="center" rowspan="1" colspan="1">Chen, D. Q., et al. (2020). Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis via modulating protein stability of &#x003b2;-catenin and &#x003b2;-catenin-mediated transcription. <italic>Therapeutic Advances in Chronic Disease</italic>, 11, 2040622320962648. <ext-link xlink:href="https://doi.org/10.1177/2040622320962648" ext-link-type="uri">https://doi.org/10.1177/2040622320962648</ext-link>
</td></tr><tr><td align="center" rowspan="1" colspan="1">GSK-J4</td><td align="center" rowspan="1" colspan="1">Mouse (DKD)</td><td align="center" rowspan="1" colspan="1">GSK-J4 improves kidney dysfunction, glomerulosclerosis, inflammation, and fibrosis in diabetic mice by regulating DKK1</td><td align="center" rowspan="1" colspan="1">Hung, P.-H., et al. (2022). The histone demethylase inhibitor GSK-J4 is a therapeutic target for the kidney fibrosis of diabetic kidney disease via DKK1 modulation. <italic>International Journal of Molecular Sciences</italic>, 23 (16), 940,907. <ext-link xlink:href="https://doi.org/10.3390/ijms23169407" ext-link-type="uri">https://doi.org/10.3390/ijms23169407</ext-link>
</td></tr></tbody></table></table-wrap><p>Klotho is an anti-aging protein that acts as an antagonist of endogenous WNT/&#x003b2;-catenin signaling. It binds to multiple WNT proteins but not to &#x003b2;-catenin, thereby blocking WNT-induced &#x003b2;-catenin activation and nuclear translocation (<xref rid="B70" ref-type="bibr">Zhou et al., 2019</xref>; <xref rid="B63" ref-type="bibr">Xie et al., 2021</xref>). In a combined Klotho treatment regimen, the G (2)/M block was bypassed, accompanied by a reduction in fibrocytokine production, inhibition of &#x003b2;-catenin activation and its downstream gene expression, and a decrease in myofibroblast activation and matrix expression (<xref rid="B49" ref-type="bibr">Satoh et al., 2012</xref>). Also, targetting zeste homolog 2 enhancer (EZH2) may be a novel therapeutic approach to the amelioration of renal fibrosis subsequent to acute kidney injury. EZH2 is a methyltransferase found upregulated in fibrotic kidneys. Inhibition of EZH2 in renal organoids with the EZH2-specific inhibitor GSK343 blocks SMAD3-dependent cis-complexes and inhibits fibroblast activation (<xref rid="B13" ref-type="bibr">Davis et al., 2022</xref>) and transcriptional inactivation of the TGF&#x003b2;1 signaling pathway (<xref rid="B27" ref-type="bibr">Jiang et al., 2021</xref>). Inhibition of EZH2 with 3-dezanepin A (3-DZNeP) can eliminate extracellular matrix protein deposition and &#x003b1;-smooth muscle actin expression in obstructed kidneys (<xref rid="B73" ref-type="bibr">Zhou et al., 2016</xref>). Furthermore, it has been shown to reduce the G2/M phase arrest of the renal tubular cell cycle and increase E-cadherin expression. 3-DZNeP has been demonstrated to decrease vimentin expression, attenuate aberrant secretion of pro-fibrotic and pro-inflammatory factors, and block M2 macrophage polarization. Additionally, it has been shown to dephosphorylate AKT and &#x003b2;-catenin <italic>in vivo</italic> and <italic>in vitro</italic>. Notably, it effectively eliminating &#x003b2;-catenin phosphorylation without affecting the expression level of total &#x003b2;-catenin (<xref rid="B71" ref-type="bibr">Zhou et al., 2023</xref>). 3-DZNeP has also been observed to inhibit the expression of Snail-1 and Twist (<xref rid="B72" ref-type="bibr">Zhou et al., 2018b</xref>).</p></sec></sec><sec sec-type="conclusion" id="s2"><title>Conclusion</title><p>Wnt signaling is essential for regulating embryonic development and adult tissue homeostasis. Dysregulation of the Wnt/&#x003b2;-catenin pathway is strongly associated with various diseases, including cancer (<xref rid="B17" ref-type="bibr">Flanagan et al., 2019</xref>) and neurodegenerative disorders (<xref rid="B45" ref-type="bibr">Ramakrishna et al., 2023</xref>). It is a key driver in cancers such as colorectal cancer, influencing EMT, MET, angiogenesis, fibroblast activation, and tumor metastasis (<xref rid="B64" ref-type="bibr">Yang et al., 2020</xref>). Excessive inhibition of Wnt signaling may disrupt tissue homeostasis, impair epithelial repair, and exacerbate neurodegenerative processes like neuron loss and synaptic dysfunction (<xref rid="B51" ref-type="bibr">Serafino et al., 2020</xref>; <xref rid="B53" ref-type="bibr">Song et al., 2021</xref>). Therefore, while targeting this pathway holds therapeutic potential for kidney fibrosis and chronic kidney disease, careful regulation is crucial to avoid adverse effects, such as increased risks of Alzheimer&#x02019;s disease. Future studies should prioritize tissue-specific and temporally precise modulation to minimize off-target effects.</p><p>This paper provides a concise overview of the recent findings of WNT/&#x003b2;-catenin signalling pathway and its relevant crosstalk between epithelial cells from the injured tubules, the proximal macrophages and fibroblasts in the context of renal fibrosis, offering insights that could enhance the treatment of renal fibrosis. Developing drugs to target the Wnt/&#x003b2;-catenin pathway is a promising approach for treating renal fibrosis. However, further precision is required regarding the temporal and spatial effects of Wnt signalling pathway in the event of kidney injury, given that the development of fibrosis is often accompanied by dynamic activation of WNT signalling and a significant heterogeneity of its related cells, including macrophages and other profibrotic cells. In conclusion, the study of Wnt signalling pathway is important and necessary, with the potential to bring further opportunities and possibilities for the study of chronic kidney disease.</p></sec></body><back><sec sec-type="author-contributions" id="s3"><title>Author contributions</title><p>CY: Writing&#x02013;original draft, Writing&#x02013;review and editing. CX: Conceptualization, Project administration, Resources, Writing&#x02013;original draft, Writing&#x02013;review and editing.</p></sec><sec sec-type="COI-statement" id="s5"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="s6"><title>Generative AI statement</title><p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="s7"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Rincon Fernandez Pacheco</surname><given-names>D.</given-names></name><name><surname>Rinaldi</surname><given-names>A.</given-names></name><name><surname>Rajewski</surname><given-names>A.</given-names></name><name><surname>Callemeyn</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys</article-title>. <source>Science</source>
<volume>383</volume>, <fpage>eadd6371</fpage>. <pub-id pub-id-type="doi">10.1126/science.add6371</pub-id>
<pub-id pub-id-type="pmid">38386758</pub-id>
</mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baudier</surname><given-names>R. L.</given-names></name><name><surname>Orlandi</surname><given-names>P. F.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>H. Y.</given-names></name><name><surname>Bansal</surname><given-names>N.</given-names></name><name><surname>Blackston</surname><given-names>J. W.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Matrix metalloproteinase-2 and CKD progression: the chronic renal insufficiency cohort (CRIC) study</article-title>. <source>Kidney Med.</source>
<volume>6</volume>, <fpage>100850</fpage>. <pub-id pub-id-type="doi">10.1016/j.xkme.2024.100850</pub-id>
<pub-id pub-id-type="pmid">39131916</pub-id>
</mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bikbov</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017</article-title>. <source>Lancet</source>
<volume>395</volume>, <fpage>709</fpage>&#x02013;<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30045-3</pub-id>
<pub-id pub-id-type="pmid">32061315</pub-id>
</mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boutet</surname><given-names>A.</given-names></name><name><surname>De Frutos</surname><given-names>C. A.</given-names></name><name><surname>Maxwell</surname><given-names>P. H.</given-names></name><name><surname>Mayol</surname><given-names>M. J.</given-names></name><name><surname>Romero</surname><given-names>J.</given-names></name><name><surname>Nieto</surname><given-names>M. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney</article-title>. <source>EMBO J.</source>
<volume>25</volume>, <fpage>5603</fpage>&#x02013;<lpage>5613</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601421</pub-id>
<pub-id pub-id-type="pmid">17093497</pub-id>
</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Breyer</surname><given-names>M. D.</given-names></name><name><surname>Susztak</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>The next generation of therapeutics for chronic kidney disease</article-title>. <source>Nat. Rev. Drug Discov.</source>
<volume>15</volume>, <fpage>568</fpage>&#x02013;<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1038/nrd.2016.67</pub-id>
<pub-id pub-id-type="pmid">27230798</pub-id>
</mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bugg</surname><given-names>D.</given-names></name><name><surname>Davis</surname><given-names>J.</given-names></name></person-group> (<year>2024</year>). <article-title>Sox9-coordinated cellular neighborhoods generate fibrosis</article-title>. <source>Cell. Stem Cell.</source>
<volume>31</volume>, <fpage>589</fpage>&#x02013;<lpage>590</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2024.04.009</pub-id>
<pub-id pub-id-type="pmid">38701754</pub-id>
</mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chae</surname><given-names>W.-J.</given-names></name><name><surname>Bothwell</surname><given-names>A. L. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Canonical and non-canonical Wnt signaling in immune cells</article-title>. <source>Trends Immunol.</source>
<volume>39</volume>, <fpage>830</fpage>&#x02013;<lpage>847</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2018.08.006</pub-id>
<pub-id pub-id-type="pmid">30213499</pub-id>
</mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Zhong</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>X. R.</given-names></name><name><surname>Tang</surname><given-names>P. M. K.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition</article-title>. <source>Mol. Ther.</source>
<volume>30</volume>, <fpage>3017</fpage>&#x02013;<lpage>3033</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymthe.2022.06.019</pub-id>
<pub-id pub-id-type="pmid">35791881</pub-id>
</mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>T. K.</given-names></name><name><surname>Knicely</surname><given-names>D. H.</given-names></name><name><surname>Grams</surname><given-names>M. E.</given-names></name></person-group> (<year>2019</year>). <article-title>Chronic kidney disease diagnosis and management: a review</article-title>. <source>Jama</source>
<volume>322</volume>, <fpage>1294</fpage>&#x02013;<lpage>1304</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2019.14745</pub-id>
<pub-id pub-id-type="pmid">31573641</pub-id>
</mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Clevers</surname><given-names>H.</given-names></name><name><surname>Nusse</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Wnt/&#x003b2;-catenin signaling and disease</article-title>. <source>Cell.</source>
<volume>149</volume>, <fpage>1192</fpage>&#x02013;<lpage>1205</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.05.012</pub-id>
<pub-id pub-id-type="pmid">22682243</pub-id>
</mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cohen</surname><given-names>C.</given-names></name><name><surname>Mhaidly</surname><given-names>R.</given-names></name><name><surname>Croizer</surname><given-names>H.</given-names></name><name><surname>Kieffer</surname><given-names>Y.</given-names></name><name><surname>Leclere</surname><given-names>R.</given-names></name><name><surname>Vincent-Salomon</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease</article-title>. <source>Nat. Commun.</source>
<volume>15</volume>, <fpage>743</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-024-44886-z</pub-id>
<pub-id pub-id-type="pmid">38272907</pub-id>
</mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dapkunas</surname><given-names>A.</given-names></name><name><surname>Rantanen</surname><given-names>V.</given-names></name><name><surname>Gui</surname><given-names>Y.</given-names></name><name><surname>Lalowski</surname><given-names>M.</given-names></name><name><surname>Sainio</surname><given-names>K.</given-names></name><name><surname>Kuure</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Simple 3D culture of dissociated kidney mesenchyme mimics nephron progenitor niche and facilitates nephrogenesis Wnt-independently</article-title>. <source>Sci. Rep.</source>
<volume>9</volume>, <fpage>13433</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-49526-x</pub-id>
<pub-id pub-id-type="pmid">31530822</pub-id>
</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davis</surname><given-names>J. L.</given-names></name><name><surname>Kennedy</surname><given-names>C.</given-names></name><name><surname>Clerkin</surname><given-names>S.</given-names></name><name><surname>Treacy</surname><given-names>N. J.</given-names></name><name><surname>Dodd</surname><given-names>T.</given-names></name><name><surname>Moss</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Single-cell multiomics reveals the complexity of TGF&#x003b2; signalling to chromatin in iPSC-derived kidney organoids</article-title>. <source>Commun. Biol.</source>
<volume>5</volume>, <fpage>1301</fpage>. <pub-id pub-id-type="doi">10.1038/s42003-022-04264-1</pub-id>
<pub-id pub-id-type="pmid">36435939</pub-id>
</mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>S. l.</given-names></name><name><surname>Lee</surname><given-names>S. Y.</given-names></name><name><surname>Koo</surname><given-names>J. K.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Choi</surname><given-names>M. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Autophagy regulates TGF-&#x003b2; expression and suppresses kidney fibrosis induced by unilateral ureteral obstruction</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>25</volume>, <fpage>2835</fpage>&#x02013;<lpage>2846</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2013101068</pub-id>
<pub-id pub-id-type="pmid">24854279</pub-id>
</mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>DiRocco</surname><given-names>D. P.</given-names></name><name><surname>Kobayashi</surname><given-names>A.</given-names></name><name><surname>Taketo</surname><given-names>M. M.</given-names></name><name><surname>McMahon</surname><given-names>A. P.</given-names></name><name><surname>Humphreys</surname><given-names>B. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Wnt4/&#x003b2;-catenin signaling in medullary kidney myofibroblasts</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>24</volume>, <fpage>1399</fpage>&#x02013;<lpage>1412</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2012050512</pub-id>
<pub-id pub-id-type="pmid">23766539</pub-id>
</mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Ren</surname><given-names>J.</given-names></name><name><surname>Gui</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Shu</surname><given-names>B.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Wnt/&#x003b2;-Catenin-Promoted macrophage alternative activation contributes to kidney fibrosis</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>29</volume>, <fpage>182</fpage>&#x02013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2017040391</pub-id>
<pub-id pub-id-type="pmid">29021383</pub-id>
</mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Flanagan</surname><given-names>D. J.</given-names></name><name><surname>Vincan</surname><given-names>E.</given-names></name><name><surname>Phesse</surname><given-names>T. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Wnt signaling in cancer: not a binary ON:OFF switch</article-title>. <source>Cancer Res.</source>
<volume>79</volume>, <fpage>5901</fpage>&#x02013;<lpage>5906</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-19-1362</pub-id>
<pub-id pub-id-type="pmid">31431458</pub-id>
</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fu</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Yuan</surname><given-names>W.</given-names></name><name><surname>Salem</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease</article-title>. <source>Kidney Int.</source>
<volume>102</volume>, <fpage>1291</fpage>&#x02013;<lpage>1304</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2022.08.026</pub-id>
<pub-id pub-id-type="pmid">36108806</pub-id>
</mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grande</surname><given-names>M. T.</given-names></name><name><surname>S&#x000e1;nchez-Laorden</surname><given-names>B.</given-names></name><name><surname>L&#x000f3;pez-Blau</surname><given-names>C.</given-names></name><name><surname>De Frutos</surname><given-names>C. A.</given-names></name><name><surname>Boutet</surname><given-names>A.</given-names></name><name><surname>Ar&#x000e9;valo</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease</article-title>. <source>Nat. Med.</source>
<volume>21</volume>, <fpage>989</fpage>&#x02013;<lpage>997</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3901</pub-id>
<pub-id pub-id-type="pmid">26236989</pub-id>
</mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gu</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Gan</surname><given-names>Y.</given-names></name><name><surname>Xiao</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Knockdown of SOX9 alleviates tracheal fibrosis through the Wnt/&#x003b2;-catenin signaling pathway</article-title>. <source>J. Mol. Med. Berl.</source>
<volume>100</volume>, <fpage>1659</fpage>&#x02013;<lpage>1670</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-022-02261-9</pub-id>
<pub-id pub-id-type="pmid">36192639</pub-id>
</mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>W.</given-names></name><name><surname>Dai</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zeng</surname><given-names>G.</given-names></name><name><surname>Monga</surname><given-names>S. P.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group> (<year>2009</year>). <article-title>Wnt/beta-catenin signaling promotes renal interstitial fibrosis</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>20</volume>, <fpage>765</fpage>&#x02013;<lpage>776</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2008060566</pub-id>
<pub-id pub-id-type="pmid">19297557</pub-id>
</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>W.</given-names></name><name><surname>Tan</surname><given-names>R. J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Nie</surname><given-names>J.</given-names></name><name><surname>Hou</surname><given-names>F. F.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Matrix metalloproteinase-7 as a surrogate marker predicts renal wnt/&#x003b2;-catenin activity in CKD</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>23</volume>, <fpage>294</fpage>&#x02013;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2011050490</pub-id>
<pub-id pub-id-type="pmid">22095947</pub-id>
</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hirohama</surname><given-names>D.</given-names></name><name><surname>Abedini</surname><given-names>A.</given-names></name><name><surname>Moon</surname><given-names>S.</given-names></name><name><surname>Surapaneni</surname><given-names>A.</given-names></name><name><surname>Dillon</surname><given-names>S. T.</given-names></name><name><surname>Vassalotti</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Unbiased human kidney tissue proteomics identifies matrix metalloproteinase 7 as a kidney disease biomarker</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>34</volume>, <fpage>1279</fpage>&#x02013;<lpage>1291</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.0000000000000141</pub-id>
<pub-id pub-id-type="pmid">37022120</pub-id>
</mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hou</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Lv</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis</article-title>. <source>Cell. Commun. Signal</source>
<volume>16</volume>, <fpage>89</fpage>. <pub-id pub-id-type="doi">10.1186/s12964-018-0300-8</pub-id>
<pub-id pub-id-type="pmid">30470231</pub-id>
</mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>L.</given-names></name><name><surname>Ding</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>W.</given-names></name></person-group> (<year>2022</year>). <article-title>Emerging therapeutic strategies for attenuating tubular EMT and kidney fibrosis by targeting wnt/&#x003b2;-catenin signaling</article-title>. <source>Front. Pharmacol.</source>
<volume>12</volume>, <fpage>830340</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.830340</pub-id>
<pub-id pub-id-type="pmid">35082683</pub-id>
</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>R.</given-names></name><name><surname>Fu</surname><given-names>P.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name></person-group> (<year>2023</year>). <article-title>Kidney fibrosis: from mechanisms to therapeutic medicines</article-title>. <source>Signal Transduct. Target. Ther.</source>
<volume>8</volume>, <fpage>129</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-023-01379-7</pub-id>
<pub-id pub-id-type="pmid">36932062</pub-id>
</mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Xiang</surname><given-names>C.</given-names></name><name><surname>Zhong</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis</article-title>. <source>Theranostics</source>
<volume>11</volume>, <fpage>361</fpage>&#x02013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.7150/thno.46360</pub-id>
<pub-id pub-id-type="pmid">33391480</pub-id>
</mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>La Russa</surname><given-names>A.</given-names></name><name><surname>Serra</surname><given-names>R.</given-names></name><name><surname>Faga</surname><given-names>T.</given-names></name><name><surname>Crugliano</surname><given-names>G.</given-names></name><name><surname>Bonelli</surname><given-names>A.</given-names></name><name><surname>Coppolino</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Kidney fibrosis and matrix metalloproteinases (MMPs)</article-title>. <source>Front. Biosci. Landmark Ed.</source>
<volume>29</volume>, <fpage>192</fpage>. <pub-id pub-id-type="doi">10.31083/j.fbl2905192</pub-id>
<pub-id pub-id-type="pmid">38812325</pub-id>
</mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Leung</surname><given-names>J. C. K.</given-names></name><name><surname>Yiu</surname><given-names>W. H.</given-names></name><name><surname>Chan</surname><given-names>L. Y. Y.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Lok</surname><given-names>S. W. Y.</given-names></name><etal/></person-group> (<year>2022a</year>). <article-title>Tubular &#x003b2;-catenin alleviates mitochondrial dysfunction and cell death in acute kidney injury</article-title>. <source>Cell. Death Dis.</source>
<volume>13</volume>, <fpage>1061</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-022-05395-3</pub-id>
<pub-id pub-id-type="pmid">36539406</pub-id>
</mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Fu</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group> (<year>2022b</year>). <article-title>The fibrogenic niche in kidney fibrosis: components and mechanisms</article-title>. <source>Nat. Rev. Nephrol.</source>
<volume>18</volume>, <fpage>545</fpage>&#x02013;<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1038/s41581-022-00590-z</pub-id>
<pub-id pub-id-type="pmid">35788561</pub-id>
</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>S.-L.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Rao</surname><given-names>S.</given-names></name><name><surname>Yeo</surname><given-names>E. J.</given-names></name><name><surname>Hudson</surname><given-names>T. E.</given-names></name><name><surname>Nowlin</surname><given-names>B. T.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Macrophage Wnt7b is critical for kidney repair and regeneration</article-title>. <source>Proc. Natl. Acad. Sci.</source>
<volume>107</volume>, <fpage>4194</fpage>&#x02013;<lpage>4199</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0912228107</pub-id>
<pub-id pub-id-type="pmid">20160075</pub-id>
</mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Little</surname><given-names>M. H.</given-names></name><name><surname>McMahon</surname><given-names>A. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Mammalian kidney development: principles, progress, and projections</article-title>. <source>Cold Spring Harb. Perspect. Biol.</source>
<volume>4</volume>, <fpage>a008300</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a008300</pub-id>
<pub-id pub-id-type="pmid">22550230</pub-id>
</mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Wnt/&#x003b2;-catenin signalling: function, biological mechanisms, and therapeutic opportunities</article-title>. <source>Signal Transduct. Target. Ther.</source>
<volume>7</volume>, <fpage>3</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-021-00762-6</pub-id>
<pub-id pub-id-type="pmid">34980884</pub-id>
</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Cellular and molecular mechanisms of renal fibrosis</article-title>. <source>Nat. Rev. Nephrol.</source>
<volume>7</volume>, <fpage>684</fpage>&#x02013;<lpage>696</lpage>. <pub-id pub-id-type="doi">10.1038/nrneph.2011.149</pub-id>
<pub-id pub-id-type="pmid">22009250</pub-id>
</mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lovisa</surname><given-names>S.</given-names></name><name><surname>LeBleu</surname><given-names>V. S.</given-names></name><name><surname>Tampe</surname><given-names>B.</given-names></name><name><surname>Sugimoto</surname><given-names>H.</given-names></name><name><surname>Vadnagara</surname><given-names>K.</given-names></name><name><surname>Carstens</surname><given-names>J. L.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis</article-title>. <source>Nat. Med.</source>
<volume>21</volume>, <fpage>998</fpage>&#x02013;<lpage>1009</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3902</pub-id>
<pub-id pub-id-type="pmid">26236991</pub-id>
</mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luo</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Wnt9a promotes renal fibrosis by accelerating cellular senescence in tubular epithelial cells</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>29</volume>, <fpage>1238</fpage>&#x02013;<lpage>1256</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2017050574</pub-id>
<pub-id pub-id-type="pmid">29440280</pub-id>
</mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maarouf</surname><given-names>O. H.</given-names></name><name><surname>Aravamudhan</surname><given-names>A.</given-names></name><name><surname>Rangarajan</surname><given-names>D.</given-names></name><name><surname>Kusaba</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>V.</given-names></name><name><surname>Welborn</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Paracrine Wnt1 drives interstitial fibrosis without inflammation by tubulointerstitial cross-talk</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>27</volume>, <fpage>781</fpage>&#x02013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2014121188</pub-id>
<pub-id pub-id-type="pmid">26204899</pub-id>
</mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miao</surname><given-names>Y.</given-names></name><name><surname>Ha</surname><given-names>A.</given-names></name><name><surname>de Lau</surname><given-names>W.</given-names></name><name><surname>Yuki</surname><given-names>K.</given-names></name><name><surname>Santos</surname><given-names>A. J. M.</given-names></name><name><surname>You</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Next-Generation surrogate Wnts support organoid growth and deconvolute frizzled pleiotropy <italic>in vivo</italic>
</article-title>. <source>Cell. Stem Cell.</source>
<volume>27</volume>, <fpage>840</fpage>&#x02013;<lpage>851</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2020.07.020</pub-id>
<pub-id pub-id-type="pmid">32818433</pub-id>
</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morgado-Pascual</surname><given-names>J. L.</given-names></name><name><surname>Suarez-Alvarez</surname><given-names>B.</given-names></name><name><surname>Marchant</surname><given-names>V.</given-names></name><name><surname>Basantes</surname><given-names>P.</given-names></name><name><surname>Tharaux</surname><given-names>P. L.</given-names></name><name><surname>Ortiz</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Type IV collagen and SOX9 are molecular targets of BET inhibition in experimental glomerulosclerosis</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>24</volume>, <fpage>486</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24010486</pub-id>
<pub-id pub-id-type="pmid">36613933</pub-id>
</mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murea</surname><given-names>M.</given-names></name><name><surname>Park</surname><given-names>J. K.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Kato</surname><given-names>H.</given-names></name><name><surname>Gruenwald</surname><given-names>A.</given-names></name><name><surname>Niranjan</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function</article-title>. <source>Kidney Int.</source>
<volume>78</volume>, <fpage>514</fpage>&#x02013;<lpage>522</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2010.172</pub-id>
<pub-id pub-id-type="pmid">20531454</pub-id>
</mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nlandu-Khodo</surname><given-names>S.</given-names></name><name><surname>Osaki</surname><given-names>Y.</given-names></name><name><surname>Scarfe</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Phillips-Mignemi</surname><given-names>M.</given-names></name><name><surname>Tonello</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Tubular &#x003b2;-catenin and FoxO3 interactions protect in chronic kidney disease</article-title>. <source>JCI Insight</source>
<volume>5</volume>, <fpage>e135454</fpage>. <pub-id pub-id-type="doi">10.1172/jci.insight.135454</pub-id>
<pub-id pub-id-type="pmid">32369448</pub-id>
</mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nusse</surname><given-names>R.</given-names></name><name><surname>Clevers</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Wnt/&#x003b2;-Catenin signaling, disease, and emerging therapeutic modalities</article-title>. <source>Cell.</source>
<volume>169</volume>, <fpage>985</fpage>&#x02013;<lpage>999</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.05.016</pub-id>
<pub-id pub-id-type="pmid">28575679</pub-id>
</mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pai</surname><given-names>C.-H.</given-names></name><name><surname>Lin</surname><given-names>S. R.</given-names></name><name><surname>Liu</surname><given-names>C. H.</given-names></name><name><surname>Pan</surname><given-names>S. Y.</given-names></name><name><surname>Hsu</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>Y. T.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis</article-title>. <source>Sci. Rep.</source>
<volume>10</volume>, <fpage>16772</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-73194-x</pub-id>
<pub-id pub-id-type="pmid">33033277</pub-id>
</mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qi</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Rong</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Snai1-induced partial epithelial-mesenchymal transition orchestrates p53-p21-mediated G2/M arrest in the progression of renal fibrosis via NF-&#x003ba;B-mediated inflammation</article-title>. <source>Cell. Death Dis.</source>
<volume>12</volume>, <fpage>44</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-020-03322-y</pub-id>
<pub-id pub-id-type="pmid">33414422</pub-id>
</mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramakrishna</surname><given-names>K.</given-names></name><name><surname>Nalla</surname><given-names>L. V.</given-names></name><name><surname>Naresh</surname><given-names>D.</given-names></name><name><surname>Venkateswarlu</surname><given-names>K.</given-names></name><name><surname>Viswanadh</surname><given-names>M. K.</given-names></name><name><surname>Nalluri</surname><given-names>B. N.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>WNT-&#x00392; catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective</article-title>. <source>Diseases</source>
<volume>11</volume>, <fpage>89</fpage>. <pub-id pub-id-type="doi">10.3390/diseases11030089</pub-id>
<pub-id pub-id-type="pmid">37489441</pub-id>
</mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raza</surname><given-names>S.</given-names></name><name><surname>Jokl</surname><given-names>E.</given-names></name><name><surname>Pritchett</surname><given-names>J.</given-names></name><name><surname>Martin</surname><given-names>K.</given-names></name><name><surname>Su</surname><given-names>K.</given-names></name><name><surname>Simpson</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function</article-title>. <source>Sci. Signal</source>
<volume>14</volume>, <fpage>eabb4282</fpage>. <pub-id pub-id-type="doi">10.1126/scisignal.abb4282</pub-id>
<pub-id pub-id-type="pmid">33653921</pub-id>
</mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ruiz-Ortega</surname><given-names>M.</given-names></name><name><surname>Rayego-Mateos</surname><given-names>S.</given-names></name><name><surname>Lamas</surname><given-names>S.</given-names></name><name><surname>Ortiz</surname><given-names>A.</given-names></name><name><surname>Rodrigues-Diez</surname><given-names>R. R.</given-names></name></person-group> (<year>2020</year>). <article-title>Targeting the progression of chronic kidney disease</article-title>. <source>Nat. Rev. Nephrol.</source>
<volume>16</volume>, <fpage>269</fpage>&#x02013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1038/s41581-019-0248-y</pub-id>
<pub-id pub-id-type="pmid">32060481</pub-id>
</mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saha</surname><given-names>S.</given-names></name><name><surname>Aranda</surname><given-names>E.</given-names></name><name><surname>Hayakawa</surname><given-names>Y.</given-names></name><name><surname>Bhanja</surname><given-names>P.</given-names></name><name><surname>Atay</surname><given-names>S.</given-names></name><name><surname>Brodin</surname><given-names>N. P.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Macrophage-derived extracellular vesicle-packaged WNTs rescue intestinal stem cells and enhance survival after radiation injury</article-title>. <source>Nat. Commun.</source>
<volume>7</volume>, <fpage>13096</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms13096</pub-id>
<pub-id pub-id-type="pmid">27734833</pub-id>
</mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Satoh</surname><given-names>M.</given-names></name><name><surname>Nagasu</surname><given-names>H.</given-names></name><name><surname>Morita</surname><given-names>Y.</given-names></name><name><surname>Yamaguchi</surname><given-names>T. P.</given-names></name><name><surname>Kanwar</surname><given-names>Y. S.</given-names></name><name><surname>Kashihara</surname><given-names>N.</given-names></name></person-group> (<year>2012</year>). <article-title>Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling</article-title>. <source>Am. J. Physiol-renal.</source>
<volume>303</volume>, <fpage>F1641</fpage>&#x02013;<lpage>F1651</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00460.2012</pub-id>
</mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schunk</surname><given-names>S. J.</given-names></name><name><surname>Floege</surname><given-names>J.</given-names></name><name><surname>Fliser</surname><given-names>D.</given-names></name><name><surname>Speer</surname><given-names>T.</given-names></name></person-group> (<year>2021</year>). <article-title>WNT-&#x003b2;-catenin signalling - a versatile player in kidney injury and repair</article-title>. <source>Nat. Rev. Nephrol.</source>
<volume>17</volume>, <fpage>172</fpage>&#x02013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1038/s41581-020-00343-w</pub-id>
<pub-id pub-id-type="pmid">32989282</pub-id>
</mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Serafino</surname><given-names>A.</given-names></name><name><surname>Giovannini</surname><given-names>D.</given-names></name><name><surname>Rossi</surname><given-names>S.</given-names></name><name><surname>Cozzolino</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Targeting the Wnt/&#x003b2;-catenin pathway in neurodegenerative diseases: recent approaches and current challenges</article-title>. <source>Expert Opin. Drug Discov.</source>
<volume>15</volume>, <fpage>803</fpage>&#x02013;<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1080/17460441.2020.1746266</pub-id>
<pub-id pub-id-type="pmid">32281421</pub-id>
</mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sheng</surname><given-names>L.</given-names></name><name><surname>Zhuang</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis</article-title>. <source>Front. Physiol.</source>
<volume>11</volume>, <fpage>569322</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2020.569322</pub-id>
<pub-id pub-id-type="pmid">33041867</pub-id>
</mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Song</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Guan</surname><given-names>X.</given-names></name><name><surname>Fiesler</surname><given-names>V.</given-names></name><name><surname>Bhuiyan</surname><given-names>M. I. H.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Activation of endothelial Wnt/&#x003b2;-catenin signaling by protective astrocytes repairs BBB damage in ischemic stroke</article-title>. <source>Prog. Neurobiol.</source>
<volume>199</volume>, <fpage>101963</fpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2020.101963</pub-id>
<pub-id pub-id-type="pmid">33249091</pub-id>
</mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Su</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>G.</given-names></name><name><surname>Tian</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group> (<year>2021</year>). <article-title>Silencing of RSPO1 mitigates obesity-related renal fibrosis in mice by deactivating Wnt/&#x003b2;-catenin pathway</article-title>. <source>Exp. Cell. Res.</source>
<volume>405</volume>, <fpage>112713</fpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2021.112713</pub-id>
<pub-id pub-id-type="pmid">34181940</pub-id>
</mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tan</surname><given-names>T. K.</given-names></name><name><surname>Zheng</surname><given-names>G.</given-names></name><name><surname>Hsu</surname><given-names>T. T.</given-names></name><name><surname>Lee</surname><given-names>S. R.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage</article-title>. <source>Lab. Invest.</source>
<volume>93</volume>, <fpage>434</fpage>&#x02013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2013.3</pub-id>
<pub-id pub-id-type="pmid">23358111</pub-id>
</mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tian</surname><given-names>X.-J.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Fu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Sequential Wnt agonist then antagonist treatment accelerates tissue repair and minimizes fibrosis</article-title>. <source>iScience</source>
<volume>23</volume>, <fpage>101047</fpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2020.101047</pub-id>
<pub-id pub-id-type="pmid">32339988</pub-id>
</mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Ren</surname><given-names>Q.</given-names></name><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>Liao</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Myeloid-derived Wnts play an indispensable role in macrophage and fibroblast activation and kidney fibrosis</article-title>. <source>Int. J. Biol. Sci.</source>
<volume>20</volume>, <fpage>2310</fpage>&#x02013;<lpage>2322</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.94166</pub-id>
<pub-id pub-id-type="pmid">38617540</pub-id>
</mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Timperi</surname><given-names>E.</given-names></name><name><surname>Gueguen</surname><given-names>P.</given-names></name><name><surname>Molgora</surname><given-names>M.</given-names></name><name><surname>Magagna</surname><given-names>I.</given-names></name><name><surname>Kieffer</surname><given-names>Y.</given-names></name><name><surname>Lopez-Lastra</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer</article-title>. <source>Cancer Res.</source>
<volume>82</volume>, <fpage>3291</fpage>&#x02013;<lpage>3306</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-22-1427</pub-id>
<pub-id pub-id-type="pmid">35862581</pub-id>
</mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trogisch</surname><given-names>F. A.</given-names></name><name><surname>Abouissa</surname><given-names>A.</given-names></name><name><surname>Keles</surname><given-names>M.</given-names></name><name><surname>Birke</surname><given-names>A.</given-names></name><name><surname>Fuhrmann</surname><given-names>M.</given-names></name><name><surname>Dittrich</surname><given-names>G. M.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Endothelial cells drive organ fibrosis in mice by inducing expression of the transcription factor SOX9</article-title>. <source>Sci. Transl. Med.</source>
<volume>16</volume>, <fpage>eabq4581</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.abq4581</pub-id>
<pub-id pub-id-type="pmid">38416842</pub-id>
</mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Sun</surname><given-names>Z.-X.</given-names></name><name><surname>Allgayer</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>H.-S.</given-names></name></person-group> (<year>2010</year>). <article-title>Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells</article-title>. <source>Oncogene</source>
<volume>29</volume>, <fpage>128</fpage>&#x02013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2009.302</pub-id>
<pub-id pub-id-type="pmid">19784072</pub-id>
</mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wozniak</surname><given-names>J.</given-names></name><name><surname>Floege</surname><given-names>J.</given-names></name><name><surname>Ostendorf</surname><given-names>T.</given-names></name><name><surname>Ludwig</surname><given-names>A.</given-names></name></person-group> (<year>2021</year>). <article-title>Key metalloproteinase-mediated pathways in the kidney</article-title>. <source>Nat. Rev. Nephrol.</source>
<volume>17</volume>, <fpage>513</fpage>&#x02013;<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1038/s41581-021-00415-5</pub-id>
<pub-id pub-id-type="pmid">33879883</pub-id>
</mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiao</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Tan</surname><given-names>R. J.</given-names></name><name><surname>Fu</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Hou</surname><given-names>F. F.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Sustained activation of wnt/&#x003b2;-catenin signaling drives AKI to CKD progression</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>27</volume>, <fpage>1727</fpage>&#x02013;<lpage>1740</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2015040449</pub-id>
<pub-id pub-id-type="pmid">26453613</pub-id>
</mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xie</surname><given-names>H.</given-names></name><name><surname>Miao</surname><given-names>N.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Ni</surname><given-names>J.</given-names></name><name><surname>Yin</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>FoxM1 promotes Wnt/&#x003b2;-catenin pathway activation and renal fibrosis via transcriptionally regulating multi-Wnts expressions</article-title>. <source>J. Cell. Mol. Med.</source>
<volume>25</volume>, <fpage>1958</fpage>&#x02013;<lpage>1971</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.15948</pub-id>
<pub-id pub-id-type="pmid">33434361</pub-id>
</mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Shang</surname><given-names>R.</given-names></name><name><surname>Yao</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/&#x003b2;-catenin signalling pathway</article-title>. <source>J. Exp. Clin. Cancer Res.</source>
<volume>39</volume>, <fpage>251</fpage>. <pub-id pub-id-type="doi">10.1186/s13046-020-01774-w</pub-id>
<pub-id pub-id-type="pmid">33222684</pub-id>
</mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.-L.</given-names></name><name><surname>Tang</surname><given-names>T. T.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Wen</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Yin</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Identification of a novel ECM remodeling macrophage subset in AKI to CKD transition by integrative spatial and single-cell analysis</article-title>. <source>Adv. Sci. (Weinh)</source>
<volume>11</volume>, <fpage>e2309752</fpage>. <pub-id pub-id-type="doi">10.1002/advs.202309752</pub-id>
<pub-id pub-id-type="pmid">39119903</pub-id>
</mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Fu</surname><given-names>H.</given-names></name><name><surname>Xiao</surname><given-names>L.</given-names></name><name><surname>Mo</surname><given-names>H.</given-names></name><name><surname>Zhuo</surname><given-names>H.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2018a</year>). <article-title>Fibroblast-specific &#x003b2;-catenin signaling dictates the outcome of AKI</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>29</volume>, <fpage>1257</fpage>&#x02013;<lpage>1271</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2017080903</pub-id>
<pub-id pub-id-type="pmid">29343518</pub-id>
</mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Fu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Min</surname><given-names>Y.</given-names></name><name><surname>Xiao</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2017b</year>). <article-title>Tubule-derived Wnts are required for fibroblast activation and kidney fibrosis</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>28</volume>, <fpage>2322</fpage>&#x02013;<lpage>2336</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2016080902</pub-id>
<pub-id pub-id-type="pmid">28336721</pub-id>
</mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Igarashi</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Tubule-specific ablation of endogenous &#x003b2;-catenin aggravates acute kidney injury in mice</article-title>. <source>Kidney Int.</source>
<volume>82</volume>, <fpage>537</fpage>&#x02013;<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2012.173</pub-id>
<pub-id pub-id-type="pmid">22622501</pub-id>
</mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Xiao</surname><given-names>L.</given-names></name><name><surname>Tan</surname><given-names>R. J.</given-names></name><etal/></person-group> (<year>2017a</year>). <article-title>Matrix metalloproteinase-7 is a urinary biomarker and pathogenic mediator of kidney fibrosis</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>28</volume>, <fpage>598</fpage>&#x02013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2016030354</pub-id>
<pub-id pub-id-type="pmid">27624489</pub-id>
</mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Yuan</surname><given-names>Q.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Wnt/&#x003b2;-catenin links oxidative stress to podocyte injury and proteinuria</article-title>. <source>Kidney Int.</source>
<volume>95</volume>, <fpage>830</fpage>&#x02013;<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2018.10.032</pub-id>
<pub-id pub-id-type="pmid">30770219</pub-id>
</mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization</article-title>. <source>Cell. Death Dis.</source>
<volume>14</volume>, <fpage>253</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-023-05782-4</pub-id>
<pub-id pub-id-type="pmid">37029114</pub-id>
</mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Xiong</surname><given-names>C.</given-names></name><name><surname>Tolbert</surname><given-names>E.</given-names></name><name><surname>Zhao</surname><given-names>T. C.</given-names></name><name><surname>Bayliss</surname><given-names>G.</given-names></name><name><surname>Zhuang</surname><given-names>S.</given-names></name></person-group> (<year>2018b</year>). <article-title>Targeting histone methyltransferase enhancer of zeste homolog-2 inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis</article-title>. <source>FASEB J.</source>
<volume>32</volume>, <fpage>fj201800237R</fpage>. <pub-id pub-id-type="doi">10.1096/fj.201800237R</pub-id>
</mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Zang</surname><given-names>X.</given-names></name><name><surname>Ponnusamy</surname><given-names>M.</given-names></name><name><surname>Masucci</surname><given-names>M. V.</given-names></name><name><surname>Tolbert</surname><given-names>E.</given-names></name><name><surname>Gong</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Enhancer of zeste homolog 2 inhibition attenuates renal fibrosis by maintaining Smad7 and phosphatase and tensin homolog expression</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>27</volume>, <fpage>2092</fpage>&#x02013;<lpage>2108</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2015040457</pub-id>
<pub-id pub-id-type="pmid">26701983</pub-id>
</mixed-citation></ref></ref-list></back></article>